SCHEMBL4935679

SCHEMBL4935679

CCCc1cc(CC(=O)O)ccc1-c1ccc(O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.50
CAMK2A Q9UQM7 1/20 0.50
PSEN1 P49768 1/20 0.46
PSEN2 P49810 1/20 0.46
APH1B Q8WW43 1/20 0.46
NCSTN Q92542 1/20 0.46
APH1A Q96BI3 1/20 0.46
PSENEN Q9NZ42 1/20 0.46
AKR1B1 P15121 2/20 0.45
ALOX5 P09917 1/20 0.44
HSD17B10 Q99714 4/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 3/20 0.44
PTPN11 Q06124 2/20 0.43
KDM4E B2RXH2 2/20 0.42
MAPT P10636 2/20 0.42
RGS12 O14924 1/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4943034 0.90 CA2 (0.55) CA2CAMK2APSEN1PSEN2APH1B
Bicarbonate SCHEMBL4566918 0.83 PTPN1 (0.50) ALOX5HSD17B10PTPN11PTPN1
SCHEMBL10345397 0.83 ALOX5 (0.46) CA2ALOX5HSD17B10ALDH1A1KDM4E
SCHEMBL27579602 0.80 ALOX5 (0.50) CA2ALOX5HSD17B10ALDH1A1KDM4E
SCHEMBL6559232 0.80 HPGD (0.61) CA2CAMK2AAKR1B1ALOX5HSD17B10
SCHEMBL786818 0.80 ESR1 (0.53) ALOX5HSD17B10PTPN11PTPN1
SCHEMBL4935609 0.79 DGAT1 (0.57) CA2CAMK2APSEN1PSEN2APH1B
SCHEMBL3811351 0.78 ESR1 (0.51) ALOX5HSD17B10PTPN11PTPN1
SCHEMBL17683870 0.78 ALDH1A1 (0.55) HSD17B10ALDH1A1HPGDPTPN11LMNA
SCHEMBL17683883 0.78 ALDH1A1 (0.55) HSD17B10ALDH1A1HPGDPTPN11LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004301-A1 Benzene Compound Having 2 or More Substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2008-01-03 US disclosed
EP-1806332-A1 BENZENE COMPOUND HAVING 2 OR MORE SUBSTITUENTS Daiichi Sankyo Company, Limited (JP) 2007-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004301-A1 Benzene Compound Having 2 or More Substituents NR1H2, NR1H3, NCOR2 CA2 4239/4885CAMK2A 2270/4885PSEN1 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.